Investigation of Transactivation of the Human C-Myc Gene by Herpes Simplex Virus Type 1

Xian Wu1997 · DOI

Abstract

This study investigates the regulatory mechanisms by which Herpes Simplex Virus Type 1 (HSV-1) transactivates the human c-myc proto-oncogene, a critical regulator of the cell cycle. Focusing on the major c-myc promoter P2, researchers utilized transient expression assays with chloramphenicol acetyltransferase (CAT) reporter plasmids to evaluate the impact of HSV-1 immediate-early (IE) proteins. The findings identify ICP4 as the primary transactivator, with ICP0 providing a synergistic boost. Crucially, the study demonstrates that viral proteins do not bind the promoter directly; instead, they hijack cellular transcription factors, specifically Sp1, E2F, and YY1, to drive gene expression.

Introduction: The Viral Hijack

Viruses are master cellular manipulators. To ensure efficient replication, HSV-1 must transform the host cell into an environment optimized for DNA synthesis. A key strategy involves upregulating c-myc, a "master switch" gene that promotes cell proliferation. While the correlation between HSV-1 infection and increased c-myc levels was established, the specific molecular pathways remained elusive. This research aimed to identify the viral effectors, the targeted DNA sequences (cis-acting elements), and the nature of the protein-DNA interactions involved in this transactivation.

Methodology

To dissect these complex interactions, a multi-pronged molecular approach was employed:

  • Transient Expression Assays: HeLa and mouse L cells were co-transfected with c-myc P2 promoter-CAT reporter constructs and plasmids expressing HSV-1 IE proteins (ICP4, ICP0, ICP27).
  • Site-Directed Mutagenesis: Mutant promoter constructs (+66mt E2F, +66mt CT-I2) were used to pinpoint the necessity of specific binding sites.
  • DNA-Protein Interaction Analysis: Electrophoretic mobility shift assays (EMSA), oligonucleotide competition, and chemical footprinting (OP-Cu) were used to map protein binding sites and determine if viral proteins interacted directly with the DNA.

Results and Discussion

The Viral Hierarchy: ICP4, ICP0, and ICP27

The assays revealed a clear hierarchy among viral proteins. ICP4 emerged as the essential engine of transactivation, being the only IE protein capable of significant independent activation. ICP0 functioned as a "turbocharger," providing a synergistic effect that increased ICP4-mediated activation by approximately 37%. Conversely, ICP27 acted as a potent repressor, reducing the combined activation of ICP4 and ICP0 by more than five-fold, suggesting a complex regulatory balance during infection.

Indirect Activation via Cellular Factors

A pivotal discovery was that HSV-1 proteins do not bind the c-myc promoter directly. Instead, the virus exploits existing cellular machinery. Footprinting and competition assays identified three key cellular transcription factors—Sp1, E2F, and YY1—that interact specifically with the P2 promoter region.

  • CT-I2 (Sp1 site): Mutation of this site reduced ICP4-mediated activation by 30%.
  • E2F site: Mutation here led to a 13% reduction in activation. The synergistic effect of ICP0 was almost entirely abolished when these sites were mutated, indicating that ICP0 primarily enhances the recruitment or activity of cellular factors at these specific "docks."

Conclusion and Future Directions

This investigation clarifies the "nuts and bolts" of HSV-1 mediated c-myc activation, highlighting a strategy of indirect recruitment rather than direct DNA binding. However, questions remain regarding the physical "handshake" between viral proteins like ICP4 and cellular factors like Sp1. Future research utilizing co-immunoprecipitation could confirm these physical complexes. Additionally, exploring the role of protein phosphorylation and cell-type specificity—particularly in neuronal models where HSV-1 establishes latency—will be crucial for a complete understanding of viral pathogenesis.

Summary updated

Abstract

The purpose of this investigation was to identify the regulatory elements involved in the transactivation of the human c-myc gene by herpes simplex virus type-1 (HSV-1). This study mainly focused on a major c-myc promoter P2 (Fig. 1). Transient expression assays were carried out with a reporter plasmid, that contained either a wild type (+66wt c-myc) or mutant (+66 mt E2F, +66mt CT -I2) c-myc promoter fused to the chloramphenicol acetyltransferase (CAT) gene, cotransfected with effector plasmids that contained the HSV-1 immediate early (IE) genes ( encoding IE proteins, ICP4, ICP0, ICP27). The transient expression assays revealed that the HSV-1 IE protein, ICP4, was a major effector in transactivation of the human c-myc P2 promoter by HSV-1, and ICPO provided a synergistic effect with ICP4. Cis-acting elements E2F and CT-12, which were potential binding sites for cellular transcription factors E2F and Spl respectively, were shown to be important in HSV-1 induced c-myc transactivation. In addition, these assays indicated that ICPO influences ICP4 mediated activation through these two sites. Electrophoretic mobility shift assays, oligonucleotide competition assays, and footprinting analysis together demonstrated that viral proteins didn't directly interact with P2 promoter region. Three cellular transcription factors, Spl, E2F, and YYl, however, specifically interacted with the P2 promoter region, of which, Spl and its related proteins SpX bound to several other sites in addition of CT-I2 site. Moreover, SpX also appeared to interact with another cellular factor that bound together with it on the P2 promoter region, and a second unknown cellular factor was also observed to interact with P2 promoter region.
BibTeX
@misc{wu1997investigation,
  author = {Xian Wu and Xian Wu},
  title = {{Investigation of Transactivation of the Human C-Myc Gene by Herpes Simplex Virus Type 1}},
  year = {1997},
  doi = {10.15760/etd.8182},
}
Figure